跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irixtar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Irixtar
Approved
STANDARD
Irixtar
Venus Remedies, Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6f66d42ed447788c
Company
Venus Remedies, Limited
Type
Standard
Approval Details
Approval Id
6f66d42ed447788c
Drug Approval Philippines Name
Irixtar
Product Name
Irixtar
Registration Number
DRP-4116-05
Brand Name
Irixtar
Generic Name
Irinotecan hydrochloride
Dosage Form
Solution for Injection (IV)
Dosage Strength
20 mg/mL
Manufacturer
Venus Remedies, Limited
Importer
Bliss Pharma Distribution and Consultancy Corp.
Distributor
Pharmastar Int'l Trading Corp.
Issuance Date
26 February 2024
Expiry Date
03 November 2027
Pharmacologic Category
Antineoplastic (Cell cycle-specific agent)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6f66d42ed447788c
Type
Standard
Back to Philippines FDA Approvals